Neurostar TMS Therapy
Device NeuroStar TMS Therapy
General payments
$1,019,033
Research payments
$83,716
Through program year 2021, $1,019,033 in general payments and $83,716 in research payments were reported against Neurostar TMS Therapy (NeuroStar TMS Therapy).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $50,158 | 682 |
| 2020 | General | $316,095 | 1,625 |
| 2020 | Research | $52,581 | 15 |
| 2019 | General | $652,780 | 3,595 |
| 2019 | Research | $31,135 | 10 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 44 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 40 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
5,902 general · 25 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.